US HEVA Immunology and Neurology Team Lead

Main Responsibilities Lead US HEOR strategy and execution for Immunology and Neurology Therapeutic Areas (TAs) across indications, ensuring generation, translation, and dissemination of high-quality, decision-relevant evidence to impact US access. Drive measurable business impact through strategic US HEVA initiatives aligned with US commercial and market access objectives. Develop and execute comprehensive US HEVA strategies aligned with Global HEVA strategy. Partner with commercial teams to translate HEVA insights into actionable business strategies. Lead US HEVA team: provide exceptional leadership, mentor/develop team members, and drive organizational change/process improvements; represent HEVA with US franchise leadership teams. Build cross-functional partnerships to support pricing/access decisions and brand strategies with robust evidence (including real‑world evidence). Present and communicate complex health economics concepts and strategic recommendations to senior leadership; influence key business decisions. Oversee design, execution, publication, and dissemination of health economics and outcomes research; develop real‑world evidence strategies and ensure scientific rigor/regulatory compliance. Lead launch strategy and evidence generation planning, including input into Integrated Evidence Generation Plans (IEGPs). Support HEOR dissemination/application (e.g., HCEI/PIE) and payer partnership studies/analytics aligned to franchise priorities. Build external stakeholder relationships (payers, HTA bodies, academic institutions); represent at conferences; collaborate with KOLs; engage with external evidence bodies (e.g., ICER, PDAB, IRA). Requirements Minimum 10 years in health economics, outcomes research, or related field. PhD, PharmD, or equivalent in health economics/epidemiology/public health/economics or related field required. Expertise in health economic modeling, real‑world evidence, and outcomes research methodologies. Deep US healthcare/payer/policy expertise with evidence‑to‑impact track record. Proven market access/reimbursement support using HEVA evidence; strong US evidence dissemination knowledge (HCEI/PIE, reactive/proactive, CFL, AMCP dossiers). Exceptional leadership and change management; strong cross‑functional influence/collaboration. Extensive Immunology or Neurology therapeutic area experience. Strong English communication and ability to synthesize complex data into actionable insights. Benefits Health and wellbeing benefits, including high‑quality healthcare, prevention/wellness programs, and at least 14 weeks’ gender‑neutral parental leave. #J-18808-Ljbffr Scorpion Therapeutics